首页> 外文期刊>Pakistan journal of medical sciences. >Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance
【24h】

Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance

机译:鲍曼不动杆菌医院感染和抗生素耐药性变化

获取原文
获取外文期刊封面目录资料

摘要

Objectives: In the intensive care setting, Acinetobacter baumannii causes ventilator-associated pneumonia and other nosocomial infections that are difficult to treat. Objective of this study was to investigate nosocomial A. baumannii infections and its changing antibiotic resistance.Methods: A total of 56 patients diagnosed with A.baumannii infections between January 2009 and December 2011 were included in the study. Diagnosis for nosocomial infections was established according to the CDC (Centers for Disease Control and Prevention) criteria. Identification of the agents isolated was carried out using conventional methods and VITEK 2 automated system, while antibiotic sensitivity testing was performed through VITEK 2 AST-N090 automated system.Results: The most common infection was nosocomial pneumonia by 43%, among which 46% were ventilator-associated pneumonia. Considering all years, the most effective antibiotics on the isolated strains were found as colistin, tigecycline, imipenem and meropenem. However resistance to imipenem and meropenem was observed to increase over years.Conclusion: The issue of increased resistance to antibiotics poses difficulty in treatment of A. baumannii infections which in turn increases the rate of mortality and cost. In order to prevent development of resistance, antibiotics must be used in an appropriate way in accompanied with proper guidance.doi: http://dx.doi.org/10.12669/pjms.295.3885How to cite this:Hakyemez IN, Kucukbayrak A, Tas T, Yikilgan AB, Akkaya A, Yasayacak A, et al. Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance. Pak J Med Sci 2013;29(5):1245-1248. doi: http://dx.doi.org/10.12669/pjms.295.3885This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:在重症监护环境中,鲍曼不动杆菌引起呼吸机相关性肺炎和其他医院感染,难以治疗。本研究的目的是调查医院内鲍曼不动杆菌的感染及其耐药性的变化。方法:2009年1月至2011年12月,共诊断为56例鲍曼不动杆菌感染的患者。根据CDC(疾病控制与预防中心)标准建立了医院感染的诊断方法。使用常规方法和VITEK 2自动化系统对分离出的药物进行鉴定,同时通过VITEK 2 AST-N090自动化系统进行抗生素敏感性测试。结果:最常见的感染是医院内肺炎,占43%,其中46%是呼吸机相关性肺炎。考虑到所有年份,发现分离出的菌株中最有效的抗生素是大肠菌素,替加环素,亚胺培南和美洛培南。然而,观察到对亚胺培南和美罗培南的抗药性随年龄增长而增加。结论:对抗生素的抗药性增加的问题给鲍曼不动杆菌感染的治疗带来了困难,这反过来又增加了死亡率和成本。为了防止产生耐药性,必须在适当的指导下以适当的方式使用抗生素。doi:http://dx.doi.org/10.12669/pjms.295.3885如何引用此信息:Hakyemez IN,Kucukbayrak A, Tas T,Yikilgan AB,Akkaya A,Yasayacak A等。医院感染鲍曼不动杆菌并改变抗生素耐药性。 Pak J Med Sci 2013; 29(5):1245-1248。 doi:http://dx.doi.org/10.12669/pjms.295.3885这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)条款分发的开放获取文章,只要适当引用了原始作品,便可以在任何介质中不受限制地使用,分发和复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号